Qunxing Ding

Kent State University, East Liverpool

Papers

1

Total Citations

64

H-Index

1

About

Qunxing Ding is a neuroscientist whose research focuses on the molecular mechanisms underlying Alzheimer’s disease and other neurodegenerative disorders. His most cited work investigates the inhibition of amyloid-beta (Aβ) oligomer assembly, a key pathological hallmark of Alzheimer’s. In a landmark 2009 study, Ding demonstrated that clioquinol and related hydroxyquinoline derivatives effectively disrupt the formation of toxic Aβ(1–42) oligomers, offering a potential therapeutic strategy for targeting early-stage protein aggregation. This paper has garnered 64 citations, reflecting its influence in the field of anti-amyloid drug discovery. Beyond this, Ding’s broader contributions include exploring metal ion dyshomeostasis and oxidative stress in neurodegeneration, as well as the role of autophagy in protein clearance. His work bridges basic molecular biology with translational applications, providing critical insights into how small molecules can modulate disease-relevant protein interactions. For students and researchers, Ding’s research exemplifies the integration of chemical biology and neuroscience to tackle complex age-related diseases, making him a notable figure in the ongoing search for effective Alzheimer’s therapies.

Research Focus

Key Achievements

1
H-Index
1
Papers
64
Total Citations
64
Avg Citations/Paper
🏆 Most Cited Paper
Clioquinol and other hydroxyquinoline derivatives inhibit Aβ(1–42) oligomer assembly
64 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Kent State University, East Liverpool

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago